Supplement reference
CDP-Choline (Citicoline)
A sourced reference on CDP-Choline (Citicoline) identity, evidence limits and safety context.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 March 2027.
Identity and product form
Citicoline, also called CDP-choline, is a choline-containing compound. It should not be confused with dietary choline intake or with an established treatment for cognitive symptoms.
Sources: National Institutes of Health, Office of Dietary Supplements
What the reviewed evidence can and cannot show
NIH’s choline material establishes choline’s nutrient role. It does not establish a cognitive, stroke or attention outcome for citicoline supplements.
Sources: National Institutes of Health, Office of Dietary Supplements
Safety and limits
Record the named compound rather than treating it as generic choline. A clinician or pharmacist can assess relevance where neurological conditions or medicines are involved.
Sources: National Institutes of Health, Office of Dietary Supplements
Published sources
- Choline Fact Sheet for Health Professionals
National Institutes of Health, Office of Dietary Supplements. Current NIH fact sheet; accessed 6 September 2026.
Supports: Nutrient or performance-research context and relevant safety limits.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.